NEW YORK (Reuters) – Celladon Corp’s shares could either double in value or collapse over the next four weeks after the drug developer announces results from a heart failure gene therapy trial, options data shows.
Later this month, Celladon is expected to report results from a mid-stage study of Mydicar, its experimental gene therapy for advanced heart failure, a condition in which the heart muscle cannot pump enough blood to meet the body’s needs.
NEW YORK (Reuters) – Exchange operator BATS Global Markets said on Thursday it plans to open a second options bourse in November as it tries to capture a larger share of the U.S. options market.
BATS Global Markets filed an application with the U.S. Securities and Exchange Commission to launch the new exchange, EDGX Options, an addition to its existing BATS Options platform.
NEW YORK, April 16 (Reuters) – Exchange operator BATS Global
Markets said on Thursday it plans to open a second options
bourse in November as it tries to capture a larger share of the
U.S. options market.
BATS Global Markets said it will file an application on
Thursday with the U.S. Securities and Exchange Commission to
launch a new exchange called EDGX Options, an addition to its
existing BATS Options platform.
NEW YORK (Reuters) – Discussions on a takeover by Intel Corp (INTC.O: Quote, Profile, Research, Stock Buzz) of smaller chip maker Altera Corp (ALTR.O: Quote, Profile, Research, Stock Buzz) may have ended for now, but activity in Altera’s options suggests traders are still hoping for a deal.
Altera shares, which jumped as much as 30 percent to $45 on March 27 on reports of a potential deal, have held most of those gains and the company’s options continue to imply a huge move for the shares in the near term. The shares were trading up 2 percent at $43.29 on Nasdaq on Wednesday.
NEW YORK (Reuters) – Perrigo Co Plc’s (PRGO.N: Quote, Profile, Research, Stock Buzz) options attracted an unusually large bullish bet days ahead of an offer from generic drugmaker Mylan NV (MYL.O: Quote, Profile, Research, Stock Buzz) to buy the company, options data shows.
On Wednesday, Mylan said it made a proposal to acquire Perrigo for about $29 billion in cash and stock, sending the Dublin, Ireland company’s shares up by more than 30 percent to an all-time high of $215.73. Mylan shares rose as much as 16 percent to a high of $69.45.
NEW YORK (Reuters) – Investors are staring at the first quarterly decline in U.S. corporate profits in six years – but the message coming out of the options market for now is not to worry.
Earnings reporting seasons are typically choppy periods for stocks, but the number of S&P 500 companies expected to see a jump in volatility is lower than where it stood a year ago or even at the same point in 2013, according to a Reuters analysis of options data.
NEW YORK (Reuters) – News that chipmaker Intel Corp (INTC.O: Quote, Profile, Research, Stock Buzz) is in talks to buy Altera Corp (ALTR.O: Quote, Profile, Research, Stock Buzz) sparked a flurry of trades in its short-term calls and could spell huge gains for some timely buyers of the options.
Altera’s shares jumped as much as 30 percent to a high of $45 on a Wall Street Journal report of talks toward a deal.
NEW YORK, March 25 (Reuters) – Accenture Plc’s
options have attracted bearish bets in recent days, as investors
appear concerned about the effect the stronger dollar will have
on the consulting and outsourcing company’s business outlook.
The company, which reports quarterly results on Thursday,
saw its shares fall 1.34 percent to $88.21 on Wednesday.
NEW YORK, March 25 (Reuters) – One trader’s bullish bet in
Kraft Foods Group Inc’s options is set to turn a
$700,000 bet into a possible paper profit of as much as $19
The company’s proposed merger with ketchup maker H.J. Heinz
Co sent shares of the maker of Velveeta cheese up by more than
40 percent – but the gains pale in comparison to the jump in the
value of its options.
NEW YORK, March 17 (Reuters) – Alibaba Group Holding Ltd’s
blockbuster IPO has been followed by a steady slide in
its stock price, which options market players do not expect to
abate, with nearly a fifth of its shares to be released for
trading on Wednesday.
The Chinese e-commerce giant’s stock soared after it first
went public in September, but the party didn’t last. Trading
just above $84 on Tuesday, the stock has dropped 29 percent from
an all-time closing high of $119.15 in November on concerns
about slowed growth in China and fake items on its website.